DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Stähli BE, Gebhard C, Duchatelle V. , et al.
Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention according to timing of infusion: insights from the SELECT-ACS trial.
J Am Heart Assoc 2016;
5 (11) e004255
Access:
We do not assume any responsibility for the contents of the web pages of other providers.